Prostate cancer risk assessment in men with an initial P.S.A. below 3 ng/mL: results from the Göteborg randomized population-based prostate cancer screening trial-Reference-Cited by-同舟云学术

Prostate cancer risk assessment in men with an initial P.S.A. below 3 ng/mL: results from the Göteborg randomized population-based prostate cancer screening trial

Published:2018-07-04 Issue:4 Volume:52 Page:256-262
ISSN:2168-1805
Container-title:Scandinavian Journal of Urology
language:en
Short-container-title:Scandinavian Journal of Urology

Author:

Frånlund Maria¹^ORCID,Arnsrud Godtman Rebecka¹^ORCID,Carlsson Sigrid V.¹²,Lilja Hans³⁴⁵,Månsson Marianne¹^ORCID,Stranne Johan¹^ORCID,Hugosson Jonas¹

Affiliation:

1. Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Göteborg, Sahlgrenska University Hospital, Göteborg, Sweden;

2. Department of Surgery (Urology Service) and Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, U.S.A;

3. Departments of Laboratory Medicine, Surgery (Urology), and Medicine (GU-Oncology), Memorial Sloan-Kettering Cancer Center, New York, NY, U.S.A;

4. Nuffield Department of Surgical Sciences, University of Oxford, Oxford, U.K;

5. Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden

Funder

Göteborg University

Swedish Research Council

Swedish Cancer Society

National Cancer Institute

National Institutes of Health/National Cancer Institute Cancer Center

National Institute for Health Research

Publisher

Informa UK Limited